Loading organizations...
Based in Hawthorne, New York, Clarapath develops robotics, machine vision, and digital automation tools to automate laboratory pathology processes. The company focuses specifically on microtomy through its flagship SectionStar system, which mechanically slices tissue samples and transfers them to slides to address labor shortages and improve diagnostic consistency across anatomic pathology labs and hospitals. Operating across two global offices, including a location in Mumbai, India, the firm is led by President and CEO Eric Feinstein and maintains strategic ties to major medical institutions, including the Mayo Clinic through the appointment of Joaquín García to the board of directors. Clarapath is currently expanding its workforce and facilities to support the commercial launch of the SectionStar platform. The enterprise was founded in 2014 by Partha Mitra as a technology spinoff from research conducted at Cold Spring Harbor Labs.
Clarapath has raised $52.0M across 2 funding rounds.
Clarapath has raised $52.0M in total across 2 funding rounds.
Clarapath has raised $52.0M across 2 funding rounds. Most recently, it raised $36.0M Series B in July 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 24, 2024 | $36M Series B | Northwell Ventures | — | Announced |
| Nov 18, 2021 | $16M Series B Plus | — | — | Announced |
Clarapath has raised $52.0M in total across 2 funding rounds.
Clarapath's investors include Northwell Ventures.
